Genomate Health
Genomate Health is a precision oncology company that offers Genomate®, a computational intelligence-powered clinical decision support system. This system helps oncologists identify the most effective…
Genomate Health
Genomate Health is a precision oncology company that offers Genomate®, a computational intelligence-powered clinical decision support system. This system helps oncologists identify the most effective…
TL;DR
What they do: AI-powered clinical decision support (Genomate®) that analyzes tumor genomic profiles to rank targeted cancer therapies
Founded: 2022
Headcount (reported): 29 employees
Recent funding: $2.25M announced Apr 2024; additional reported investments including Seed ($5.7M, Oct 2022) and a $2.0M entry in 2025
Company Overview
Problem Domain
Precision oncology; matching targeted therapies to individual tumor molecular profiles
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
$5.7M
Reported seed round; company spinout activity noted in mid-2022
$2.25M
Announced financing to develop computational model and pursue regulatory clearance
$2.0M
Reported investment tied to U.S. expansion
Investor Signal
“Oktogon Ventures and Oncompass Medicine/related investors; additional investors reported include STRT Holding Nyrt and confidential investors”
Founders
What we do
Join the Team
We are launching a technology-enabled, physician-led oncology second-opinion program supported by Genomate’s platform and are seeking licensed oncologists to join us as independent contractors.
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |